UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 159

Sortiert nach

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism

Journal of thrombosis and thrombolysis, 2010-08, Vol.30 (2), p.215-219

2010

Link zum Volltext

Verfügbarkeit prüfen

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

British journal of haematology, 2006-07, Vol.134 (2), p.227-232

2006

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy

Thrombosis research, 2000-11, Vol.100 (4), p.279-286

2000

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy: A Prospective Multicenter Study

Thrombosis research, 2000-11, Vol.100 (4), p.279-286

2000

Link zum Volltext

Verfügbarkeit prüfen

The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate

Thrombosis and haemostasis, 1993-09, Vol.70 (3), p.443

1993

Link zum Volltext

Verfügbarkeit prüfen

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

Thrombosis research, 2003-03, Vol.109 (5), p.333-339

2003

Link zum Volltext

Verfügbarkeit prüfen

Age‐adjusted D‐dimer, clinical pre‐test probability‐adjusted D‐dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis

American journal of hematology, 2023-11, Vol.98 (11), p.1772-1779

2023

Link zum Volltext

Verfügbarkeit prüfen

Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence

Internal and emergency medicine, 2013-04, Vol.8 (3), p.229-236

2013

Link zum Volltext

Verfügbarkeit prüfen

Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy

Journal of thrombosis and thrombolysis, 2018-04, Vol.45 (3), p.345-352

2018

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulant therapy for symptomatic calf deep vein thrombosis

The Lancet. Haematology, 2017-04, Vol.4 (4), p.e156-e156

2017

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication

Cochrane database of systematic reviews, 2014-05, Vol.2014 (5), p.CD001999

2014

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation: Heparins and Vitamin K Antagonists

Practical Hemostasis and Thrombosis, 2017, p.240-252

2017

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study

Blood transfusion = Trasfusione del sangue, 2020-11, Vol.18 (6), p.486-495

2020

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs

European journal of internal medicine, 2020-10, Vol.80, p.73-77

2020

Link zum Volltext

Verfügbarkeit prüfen

Antipyretic analgesics

Side Effects of Drugs Annual, 1991, Vol.15, p.85-91

1991

Link zum Volltext

Verfügbarkeit prüfen

ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent

Current opinion in molecular therapeutics, 2009-06, Vol.11 (3), p.322

Cosmi, Benilde

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK)

Haematologica (Roma), 2000-08, Vol.85 (8), p.826

2000

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the risk of bleeding in patients undergoing surgery or invasive procedures: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)

Thrombosis research, 2009-11, Vol.124 (5), p.e6-e12

2009

Link zum Volltext

Verfügbarkeit prüfen

Biological Determinants of Fasting and Postload Plasma Homocysteine Levels in Healthy Italian Subjects

Turkish journal of haematology, 2002-06, Vol.19 (2), p.213-223

2002

Link zum Volltext

Verfügbarkeit prüfen

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

BMJ open, 2020-11, Vol.10 (11), p.e040449

2020

Link zum Volltext

Verfügbarkeit prüfen

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients

Thrombosis and haemostasis, 2009-08, Vol.102 (2), p.268

2009

Link zum Volltext

Verfügbarkeit prüfen

C0310 Risk stratification models to predict bleeding events in very old patients on VKA treatment for venous thromboembolism. Results of a prospective multicenter study

Thrombosis research, 2012-10, Vol.130, p.S120-S121

2012

Link zum Volltext

Verfügbarkeit prüfen

Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort

Cerebrovascular diseases (Basel, Switzerland), 2023-04, Vol.52 (2), p.218-225

2023

Link zum Volltext

Verfügbarkeit prüfen

Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study

Thrombosis and haemostasis, 2010-06, Vol.103 (6), p.1152

2010

Link zum Volltext

Verfügbarkeit prüfen

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Thrombosis and haemostasis, 1990, Vol.63 (2), p.204

1990

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(154)
Buchkapitel
(3)
Berichte
(1)
Texte
(1)

Sprache

Englisch
(159)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(126)
Humans
(110)
Hematology
(75)
Female
(66)
Male
(64)
Cardiovascular System & Cardiology
(61)
Peripheral Vascular Disease
(55)
Aged
(54)
Middle Aged
(53)
Risk Factors
(50)
Biological And Medical Sciences
(47)
Medical Sciences
(47)
Adult
(42)
Venous Thromboembolism
(36)
Recurrence
(35)
Anticoagulants - Therapeutic Use
(33)
Aged, 80 And Over
(31)
Anticoagulants - Administration & Dosage
(29)
Prospective Studies
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy

Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy: A Prospective Multicenter Study

The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

Age‐adjusted D‐dimer, clinical pre‐test probability‐adjusted D‐dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis

Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence

Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy

Anticoagulant therapy for symptomatic calf deep vein thrombosis

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication

Anticoagulation: Heparins and Vitamin K Antagonists

Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study

Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs

Antipyretic analgesics

ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent

Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK)

Assessment of the risk of bleeding in patients undergoing surgery or invasive procedures: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)

Biological Determinants of Fasting and Postload Plasma Homocysteine Levels in Healthy Italian Subjects

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients

C0310 Risk stratification models to predict bleeding events in very old patients on VKA treatment for venous thromboembolism. Results of a prospective multicenter study

Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort

Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Suchergebnisse filtern